Praxis Precision Medicines, Inc. (PRAX)
241.76
-6.48
(-2.61%)
USD |
NASDAQ |
Oct 16, 16:00
242.00
+0.24
(+0.10%)
After-Hours: 20:00
Praxis Precision Medicines Cash and Short Term Investments (Quarterly) : 758.55M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 758.55M |
| March 31, 2026 | 786.86M |
| December 31, 2025 | 599.33M |
| September 30, 2025 | 267.16M |
| June 30, 2025 | 301.28M |
| March 31, 2025 | 327.99M |
| December 31, 2024 | 392.57M |
| September 30, 2024 | 357.03M |
| June 30, 2024 | 351.88M |
| March 31, 2024 | 207.42M |
| December 31, 2023 | 81.30M |
| September 30, 2023 | 101.08M |
| June 30, 2023 | 124.30M |
| March 31, 2023 | 85.82M |
| Date | Value |
|---|---|
| December 31, 2022 | 100.49M |
| September 30, 2022 | 123.74M |
| June 30, 2022 | 165.40M |
| March 31, 2022 | 222.52M |
| December 31, 2021 | 275.91M |
| September 30, 2021 | 314.97M |
| June 30, 2021 | 340.20M |
| March 31, 2021 | 271.41M |
| December 31, 2020 | 297.21M |
| September 30, 2020 | 114.77M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 44.82M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 874.00M |
| Insmed, Inc. | 1.160B |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Ironwood Pharmaceuticals, Inc. | 79.13M |
| Xencor, Inc. | 456.45M |